60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP NASDAQ) stock market data APIs
$1.4472
0.07(4.8%)
as of July 18, 2025
Try our APIs with
free plan!
60 Degrees Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Prev. Close
1.4472
Open
1.5169
High
1.5169
Low
1.4084
52 wk Range
1.41-14.58
Market Cap
2 224 K
Shares Outstanding
1 473 K
Revenue
802 K
EPS
-1.56
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 60 Degrees Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental Data
60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue: 802 K
- EBITDA: -10 224 947
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-05-15
- EPS/Forecast: -0.11
Get 60 Degrees Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
60 Degrees Pharmaceuticals, Inc. Common Stock News
New
60 Degrees Pharmaceuticals announces pricing of up to $10 million public offering
* 60 Degrees Pharmaceuticals (NASDAQ:SXTP [https://seekingalpha.com/symbol/SXTP]) announced on Tuesday the pricing of a public offering of 2.63 million shares of the company’s common stock and acc...
60 Degrees Pharma targets $245 million market for babesiosis treatment
WASHINGTON - 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) announced Tuesday it has determined the maximum commercial market for its drug ARAKODA (tafenoquine) for treatment of human babesiosis to be...
60 Degrees Pharmaceuticals stock surges on canine babesiosis treatment plans
Investing.com -- 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) stock jumped 20% after the company announced plans to pursue a Minor Use Minor Species (MUMS) designation from the FDA for its tafenoqui...
Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) stands against other st...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
